Approved Email Benchmarks | Free Pharma Email Marketing Performance Tool

Enter Your Approved Email Campaign Data

Input your monthly Approved Email metrics to benchmark against pharma industry standards for your therapeutic area.

Total Emails Sent (Monthly) Total Approved Emails sent in the month

Emails Opened Unique opens tracked by your platform

Emails Clicked Total unique click-throughs

Opt-Outs / Unsubscribes HCPs who opted out this month

Bounced Emails Hard + soft bounces combined

Therapeutic Area Benchmarks vary by therapeutic area

Email Type Different email types have different benchmarks

Your Approved Email Benchmark Results

Open Rate

Click Rate

Click-to-Open Rate (CTOR)

Opt-Out Rate

Deliverability Rate

Overall Engagement Grade

Performance vs Industry: --

Your Metrics vs. Therapeutic Area Benchmarks

Open Rate --

Click Rate --

Click-to-Open Rate --

Opt-Out Rate (lower is better) --

Improvement Recommendations

Approved Email Best Practices for Pharma Marketing

● Approved Email is the backbone of pharma multichannel engagement. Unlike traditional marketing email, Approved Emails in pharmaceutical marketing must go through Medical-Legal-Regulatory (MLR) review before deployment. Platforms like Veeva CRM Approved Email (AE) and Veeva Vault PromoMats ensure every piece of content is compliant with FDA regulations, ISI requirements, and fair balance provisions before it reaches an HCP inbox.
● Benchmarks vary significantly by therapeutic area and email type. Rare Disease emails consistently outperform other therapeutic areas with open rates exceeding 30%, driven by smaller, highly engaged specialist audiences. Respiratory and Cardio-Metabolic campaigns tend to see lower engagement due to larger, more saturated HCP audiences. Rep-Triggered Emails (RTEs) typically outperform marketing Approved Emails by 15-25% on open rates because they carry a personal sender relationship.
● Click-to-Open Rate (CTOR) is the most actionable metric for content optimization. While open rates reflect subject line effectiveness and sender recognition, CTOR isolates content quality by measuring clicks only among those who opened. A CTOR below 15% signals that your email content, call-to-action design, or resource offerings need improvement regardless of how strong your open rate is.
● Opt-out rate is a compliance and relationship health indicator. In pharma, opt-outs are more than a marketing metric. They directly impact your ability to communicate with HCPs across all channels. An opt-out rate above 0.5% per send signals over-frequency, irrelevant content, or poor audience targeting. Once an HCP opts out, re-engagement becomes extremely difficult due to regulatory consent requirements.
● Veeva CRM integration enables closed-loop measurement. By connecting Approved Email engagement data back to CRM activity records, field teams and marketing can see which email content fragments drive downstream behaviors like sample requests, speaker program registrations, and portal logins. This closed-loop approach transforms email from a broadcast channel into a measurable component of your omnichannel HCP engagement strategy.
● Deliverability directly impacts your sender reputation and future campaign success. Pharma email deliverability should consistently exceed 95%. High bounce rates damage your domain reputation with email service providers, causing future emails to land in spam folders. Maintain clean HCP email lists through regular validation against NPI databases and third-party data providers like IQVIA or Definitive Healthcare.

Approved Email Performance Benchmarks

Enter Your Approved Email Campaign Data

Your Approved Email Benchmark Results

Your Metrics vs. Therapeutic Area Benchmarks

Improvement Recommendations

Approved Email Best Practices for Pharma Marketing

Related Tools

Get Weekly Channel Analytics Insights